Schilde, Flemish Region, Belgium
Chief Financial Officer (CFO) | Interim CFO | Scale-ups | Finance Transformation | Value Creation | IPO & IFRS Expert Strategic and hands-on Chief Financial Officer with 25+ years of international experience across biotech, life sciences, renewable energy, industrial and services sectors. Extensive experience in scale-ups, finance transformation, value creation programs, IPO readiness, financial restructuring and international growth environments. Strong track record in supporting CEOs, boards, shareholders and investors with strategic finance leadership and operational execution. Core expertise includes: • CFO leadership & finance management • Scale-ups & high-growth companies • Finance transformation & process optimization • Value creation & performance improvement • FP&A, budgeting, forecasting & financial modelling • Financial reporting & group consolidation • IFRS conversion & complex IFRS environments • IFRS reporting, technical accounting & audit readiness • Specific IFRS topics including revenue recognition, consolidations, carve-outs, financial instruments and lease accounting • IPO readiness (Nasdaq, Euronext, TSE) • Investor relations & fundraising • M&A, due diligence, valuations & carve-outs • Cash flow optimization & working capital management • Strategic planning & business partnering • Governance, internal controls & compliance • Leading and developing international finance teams Strong experience in listed companies, private equity-backed environments, multinational groups and capital-intensive businesses. Trusted advisor in: • Business transformation • Organizational scaling • Financial restructuring • International expansion • Board & investor communications • Operational finance improvement Open to: • CFO roles • Interim CFO assignments • Fractional CFO mandates • Strategic finance leadership positions • Finance transformation projects • IPO & IFRS advisory engagements Industries: Biotech | Life Sciences | Renewable Energy | Industrial | Technology | Services Locations: Belgium | Netherlands | International
Permanent and interim roles as - CFO/FD - Group Controller / Consolidation Interim Management / Consultant: focus on: - Interim CFO/FD - IPO-preparation - IFRS conversions - Financial reporting - Consolidation - Carve-outs - ...
Responsible for the financial leadership of Suerickx Group, including strategy, performance management, and governance. Partnering with the executive team to drive sustainable growth, profitability, and operational excellence.
Imcyse is a clinical-stage biopharmaceutical company pioneering the development of a new class of active, specific immunotherapies for the treatment of severe, chronic autoimmune diseases. The company’s unique technology platform has the potential to address a wide range of indications in the vast field of immunology.